Loss-of-function mutations or deletions in NF2 cause neurofibromatosis type 2, a multiple tumour forming disease of the nervous system, characterized by the development of bilateral schwannomas, as well as meningiomas and ependymomas (Petrilli & Fernández-Valle, 2016). This evidence concerns the gene NF2 and ependymoma.